CAS 1349796-36-6
:N-[4-[[[3-[(3,5-Dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methylbenzamide
Description:
N-[4-[[[3-[(3,5-Dimethoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-3-methoxy-4-methylbenzamide, identified by its CAS number 1349796-36-6, is a synthetic organic compound characterized by its complex molecular structure, which includes multiple aromatic rings and functional groups such as amines, sulfonamides, and methoxy groups. This compound is typically studied for its potential biological activity, particularly in the context of medicinal chemistry, where it may exhibit properties relevant to drug development. The presence of the quinoxaline moiety suggests potential interactions with biological targets, possibly influencing pathways related to cancer or other diseases. Its solubility, stability, and reactivity can vary based on the specific conditions, such as pH and solvent, making it important for researchers to consider these factors in experimental designs. Overall, this compound represents a class of molecules that may have significant implications in pharmacology and therapeutic applications.
Formula:C31H29N5O6S
Synonyms:- Xl765
- Xl-765
- Sar245409
- Voxtalisib
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 5 products.
N-(4-(N-(3-((3,5-Dimethoxyphenyl)Amino)Quinoxalin-2-Yl)Sulfamoyl)Phenyl)-3-Methoxy-4-Methylbenzamide
CAS:N-(4-(N-(3-((3,5-Dimethoxyphenyl)Amino)Quinoxalin-2-Yl)Sulfamoyl)Phenyl)-3-Methoxy-4-MethylbenzamidePurity:98+%Molecular weight:599.66g/molPI3K-IN-1
CAS:PI3K-IN-1 (Voxtalisib Analogue) is a dual inhibitor of mTOR/PI3K, mostly for p110γ , also inhibits DNA-PK and mTOR.Formula:C31H29N5O6SPurity:97.03% - 98%Color and Shape:SolidMolecular weight:599.66



